|
.
|
|
0 (hodnocen0 x )
|
|
BK
|
|
|
|
4th edition
|
|
Lyon : International Agency for Research on Cancer, 2018
|
|
470 stran : barevné ilustrace ; 27 cm
|
|
|
|
|
|
ISBN 978-92-832-2440-2 (brožováno)
|
|
World Health Organization classification of tumours
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Nad názvem: WHO, OMS, International Agency for Research on Cancer (IARC)
|
|
Obsahuje bibliografii na stranách 415-461 a rejstřík
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
001484728
|
|
Contents // -? Classification of skin tumours 10 // classification of skin tumours 14 // Carcinoma of skin 14 // Skin carcinoma of the head and neck 15 // Carcinoma of skin of the eyelid 16 // Ma gnant melanoma of skin 17 // Verkel cell carcinoma of skin 19 // Soft tissue sarcoma of skin 20 // rnary cutaneous lymphomas 21 // ’ Keratinocytic/epidermal tumours 23 // traduction 24 // Carcinomas 24 // Carcinoma precursors and benign simulants 25 // Carcinomas // Basal cell carcinoma 26 // Nodular basal cell carcinoma 27 // Superficial basal cell carcinoma 28 // Micronodular basal cell carcinoma 29 // Infiltrating basal cell carcinoma 30 // Sclerosing/morphoeic basal cell carcinoma 30 // Basosquamous carcinoma 31 // Pigmented basal cell carcinoma 32 // Basal cell carcinoma with sarcomatoid differentiation 32 Basal cell carcinoma with adnexal differentiation 33 // Fibroepithelial basal cell carcinoma 34 // Squamous cell carcinoma 35 // Squamous cell carcinoma 35 // Keratoacanthoma 36 // Acantholytic squamous cell carcinoma 38 // Spindle cell squamous cell carcinoma 40 // Verrucous squamous cell carcinoma 41 // Adenosquamous carcinoma 42 // Clear cell squamous cell carcinoma 43 // Other (uncommon) variants 44 // Squamous cell carcinoma in situ (Bowen disease) 46 // Merkel cell carcinoma // Carcinoma precursors and benign simulants // Premalignant keratoses 51 // Actinic keratosis 31 // Arsenical keratosis 52 // PUVA keratosis 53 // Verrucae 34 // Verruca vulgaris 34 // Verruca plantaris
|
|
55 // Verruca plana 56 // Benign acanthomas/keratoses 57 // Seborrhoeic keratosis 57 // Solar lentigo 59 // Lichen planus-like keratosis 60 // Clear cell acanthoma 60 // Large cell acanthoma 61 // Warty dyskeratoma 62 // Other benign keratoses 63 // 2 // Melanocytic tumours // Introduction // Melanocytic tumour classification and the // pathway concept of melanoma pathogenesis Genomic landscape of melanoma Melanocytic tumours in intermittently sun-exposed skin Low-CSD melanoma (superficial spreading melanoma) Simple lentigo and lentiginous melanocytic naevus Junctional, compound, and dermal naevi Dysplastic naevus Naevus spilus // Special-site naevi (of the breast, axilla, scalp, and ear) Halo naevus Meyerson naevus Recurrent naevus // Deep penetrating naevus and melanocytoma Pigmented epithelioid melanocytoma Combined naevus, including combined B/4P7-inactivated naevus/ melanocytoma // Melanocytic tumours in chronically sun-exposed skin Lentigo maligna melanoma Desmoplastic melanoma Spitz tumours // Malignant Spitz tumour (Spitz melanoma) // Spitz naevus // Pigmented spindle cell naevus (Reed naevus) Melanocytic tumours in acral skin Acral melanoma Acral naevus // Genital and mucosal melanocytic tumours Mucosal melanomas (genital, oral, sinonasal) // Genital naevus // Melanocytic tumours arising in blue naevus Melanoma arising in blue naevus Blue naevus and cellular blue naevus Mongolian spot // Naevus of Ito and naevus of Ota Melanocytic tumours arising in congenital naevi Melanoma
|
|
arising in giant congenital naevus Congenital melanocytic naevus Proliferative nodules in congenital melanocytic naevus Ocular melanocytic tumours Uveal melanoma Conjunctival melanoma // Conjunctival melanocytic intraepithelial neoplasia/ primary acquired melanosis Conjunctival naevus // Nodular, naevoid, and metastatic melanomas Nodular melanoma Naevoid melanoma Metastatic melanoma // 65 // 66 // 66 // 72 // 76 // 76 // 78 // 80 // 82 // 87 // 89 // 91 // 93 // 94 // 95 97 // 99 // 102 // 102 // 105 // 108 // 108 // 111 // 114 // 116 // 116 // 119 // 121 // 121 // 123 // 124 124 126 // 130 // 131 // 132 132 134 // 136 // 137 137 139 // 141 // 143 // 145 // 145 // 147 // 150 // 3 Appendageal tumours 153 // Introduction 154 // Malignant tumours with apocrine and eccrine differentiation 155 Adnexal adenocarcinoma not otherwise specified 155 // Microcystic adnexal carcinoma 157 // Porocarcinoma 159 // Malignant neoplasms arising from spiradenoma, // cylindroma, or spiradenocylindroma 161 // Malignant mixed tumour 163 // Hidradenocarcinoma 164 // Mucinous carcinoma 166 // Endocrine mucin-producing sweat gland carcinoma 168 // Digital papillary adenocarcinoma 170 // Adenoid cystic carcinoma 172 // Apocrine carcinoma 174 // Squamoid eccrine ductal carcinoma 176 // Syringocystadenocarcinoma papilliferum 177 // Secretory carcinoma 179 // Cribriform carcinoma 180 // Signet-ring cell/histiocytoid carcinoma 182 // Benign tumours with apocrine and eccrine differentiation 183 Hidrocystoma/cystadenoma
|
|
183 // Syringoma 184 // Poroma 185 // Syringofibroadenoma 186 // Hidradenoma 187 // Spiradenoma 189 // Cylindroma 190 // Tubular adenoma 191 // Syringocystadenoma papilliferum 192 // Mixed tumour 193 // Myoepithelioma 194 // Malignant tumours with follicular differentiation 195 // Pilomatrical carcinoma 195 // Proliferating trichilemmal tumour 196 // Trichoblastic carcinoma/carcinosarcoma 197 // Trichilemmal carcinoma 199 // Benign tumours with follicular differentiation 201 // Trichoblastoma 201 // Pilomatricoma 203 // Trichilemmoma 204 // Trichofolliculoma 206 // Pilar sheath acanthoma 207 // Tumour of the follicular infundibulum 208 // Melanocytic matricoma 209 // Spindle cell-predominant trichodiscoma 210 // Tumours with sebaceous differentiation 211 // Sebaceous carcinoma 211 // Sebaceous adenoma 213 // Sebaceoma 214 // Site-specific tumours 216 // Mammary Paget disease 216 // Extramammary Paget disease 217 // Adenocarcinoma of anogenital mammary-like glands 219 // Hidradenoma papilliferum 220 // Fibroadenoma and phyllodes tumour of anogenital // mammary-like glands 221 // 4 Tumours of haematopoietic and lymphoid origin 223 // Introduction 224 // Mycosis fungoides 226 // Variants of mycosis fungoides 231 // Folliculotropic mycosis fungoides 231 // Granulomatous slack skin 232 // Pagetoid reticulosis 233 // Sézary syndrome 234 // Primary cutaneous CD30+ T-cell // lymphoproliferative disorders 236 // Lymphomatoid papulosis 236 // Primary cutaneous anaplastic large cell lymphoma
|
|
238 // Cutaneous adult T-cell leukaemia/lymphoma 240 // Subcutaneous panniculitis-like T-cell lymphoma 242 // Cutaneous manifestations of chronic active EBV infection 244 Extranodal NK/T-cell lymphoma, nasal type 246 // Primary cutaneous peripheral T-cell lymphomas, // rare subtypes 248 // Primary cutaneous gamma-delta T-cell lymphoma 248 // Primary cutaneous CD8+ aggressive epidermotropic // cytotoxic T-cell lymphoma 249 // Primary cutaneous acral CD8+ T-cell lymphoma 250 // Primary cutaneous CD4+ small/medium T-cell // lymphoproliferative disorder 252 // Secondary cutaneous involvement in T-cell lymphomas // and leukaemias 254 // Systemic anaplastic large cell lymphoma 254 // Angioimmunoblastic T-cell lymphoma 254 // T-cell prolymphocytic leukaemia 255 // Primary cutaneous marginal zone (MALT) lymphoma 256 // Primary cutaneous follicle centre lymphoma 258 // Primary cutaneous diffuse large ?-cell lymphoma, leg type 260 Intravascular large ?-cell lymphoma 262 // EBV-positive mucocutaneous ulcer 263 // Lymphomatoid granulomatosis 265 // Cutaneous involvement in primarily extracutaneous // ?-cell lymphomas and leukaemias 266 // Mantle cell lymphoma 266 // Burkitt lymphoma 267 // Chronic lymphocytic leukaemia/ // small lymphocytic lymphoma 268 // T-lymphoblastic and B-lymphoblastic leukaemia/lymphoma 270 Elastic plasmacytoid dendritic cell neoplasm 271 // Cutaneous involvement in myeloid leukaemia 273 // Cutaneous mastocytosis 275 // Introduction to histiocytic and dendritic cell
|
|
neoplasms 279 // Langerhans cell histiocytosis 281 // Indeterminate cell histiocytosis/indeterminate dendritic // cell tumour 283 // Rosai-Dorfman disease 284 // Juvenile xanthogranuloma 285 // Erdheim-Chester disease 287 // Reticulohistiocytosis 289 // 5 Sort tissue tumours 291 // rrccjction 292 // Aioocytic tumours 294 // Atypical lipomatous tumour 294 // P omorphic liposarcoma 295 // _poma 296 // Sc ndle cell/pleomorphic lipoma 298 // ??? 300 // \\aevus lipomatosus superficialis 301 // r c - :c astio, myofibroblastic, and fibrohistiocytic tumours 302 V inflammatory fibroblastic sarcoma 302 // Demiatofibrosarcoma protuberans and variants 304 // -’exiform fibrohistiocytic tumour 307 // Superficial fibromatosis 308 // Dermatofibroma (fibrous histiocytoma) and variants 310 // Eoithelioid fibrous histiocytoma 313 // Rbromas 314 // Fibroma of tendon sheath 314 // Calcifying aponeurotic fibroma 314 // Sclerotic fibroma 315 // Nuchal-type fibroma 315 // Gardner fibroma 316 // Pleomorphic fibroma 316 // Elastofibroma 317 // Collagenous fibroma 317 // Superficial acral fibromyxoma 318 // Cutaneous myxoma 319 // Dermatomyofibroma 321 // Myofibroma and myofibromatosis 322 // Plaque-like CD34+ dermal fibroma 324 // Nodular fasciitis 326 // Smooth muscle tumours 328 // Cutaneous leiomyomas and variants 328 // Cutaneous leiomyosarcoma (atypical smooth // muscle tumour) 330 // Myojpericytic tumours 331 // Glomus tumour and variants 331 // Myopericytoma and variants 333 // Angioleiomyoma 334
|
|
// . ascular tumours 335 // Cutaneous angiosarcoma 335 // Haemangioendotheliomas 337 // Composite haemangioendothelioma 337 // Kaposiform haemangioendothelioma 337 // Pseudomyogenic haemangioendothelioma 338 // Retiform haemangioendothelioma 339 // Epithelioid haemangioendothelioma 339 // Kaposi sarcoma 341 // Atypical vascular lesion 344 // Cutaneous epithelioid angiomatous nodule 345 // Haemangiomas 346 // Cherry haemangioma 346 // Sinusoidal haemangioma 346 // Microvenular haemangioma 347 // Hobnail haemangioma 347 // Glomeruloid haemangioma 348 // Spindle cell haemangioma 349 // Epithelioid haemangioma 349 // Tufted haemangioma 350 // Angiokeratoma 351 // Infantile haemangioma 351 // Congenital non-progressive haemangiomas: rapidly involuting congenital haemangioma and non-involuting congenital haemangioma 352 // Lobular capillary haemangioma 353 // Verrucous venous malformation 354 // Arteriovenous malformation 355 // Lymphangioma (superficial lymphatic malformation) 356 // Neural tumours 358 // Neurofibroma and variants 358 // Solitary circumscribed neuroma 360 // Dermal nerve sheath myxoma 361 // Perineurioma 362 // Granular cell tumour 364 // Schwannoma 365 // Malignant peripheral nerve sheath tumour 367 // Tumours of uncertain differentiation 368 // Atypical fibroxanthoma and variants 368 // Pleomorphic dermal sarcoma 370 // Myxofibrosarcoma 371 // Epithelioid sarcoma 373 // Dermal clear cell sarcoma 374 // Ewing sarcoma 375 // Primitive non-neural granular cell tumour
|
|
376 // Cellular neurothekeoma 377 // 6 Inherited tumour syndromes associated with // skin malignancies 379 // Introduction 380 // Familial melanoma 383 // Xeroderma pigmentosum 386 // Naevoid basal cell carcinoma syndrome (Gorlin syndrome) 388 Carney complex 391 // BAP1 tumour predisposition syndrome 393 // Muir-Torre syndrome 395 // Contributors 398 // Declaration of interests 409 // IARC/WHO Committee for ICD-0 410 // Sources of figures and tables 411 // References 415 // Subject index 462 // List of abbreviations 470
|